Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Oct-17 8:12 PM View:  | Chang David D EVP, R&D, Chief Medical Off. | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 38,675 | -- | -- | (70%) 55.28K to 16.61K | |
| 05-Oct-17 8:11 PM View: | Butitta Cynthia M Chief Operating Officer | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 93,667 | -- | -- | (100%) 93.67K to 0 | |
| 05-Oct-17 8:23 PM View: | Doumani Roy Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 1,807 | -- | -- | (1%) 177.49K to 175.69K | |
| 05-Oct-17 8:28 PM View: | Peacock Jonathan M Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 1,807 | -- | -- | (3%) 69.74K to 67.93K | |
| 05-Oct-17 8:21 PM View: | Ruchefsky Steven B Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 205,586 | -- | -- | (100%) 205.59K to 0 | |
| 05-Oct-17 8:28 PM View: | Peacock Jonathan M Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 67,932 | $180.00 | $12,227,800.00 | (100%) 67.93K to 0 | |
| 05-Oct-17 8:16 PM View: | Tomasello Shawn Chief Commercial Officer | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 39,933 | -- | -- | (71%) 56.07K to 16.14K | |
| 05-Oct-17 8:24 PM View: | Humer Franz B Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 1,807 | -- | -- | (28%) 6.43K to 4.62K | |
| 05-Oct-17 8:27 PM View: | Clark Ian T Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 1,776 | $180.00 | $319,680.00 | (100%) 1.78K to 0 | |
| 05-Oct-17 8:23 PM View: | Doumani Roy Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 25,065 | $180.00 | $4,511,700.00 | (100%) 25.07K to 0 | |
| 05-Oct-17 8:10 PM View: | Belldegrun Arie Chairman, President and CEO Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 159,160 | -- | -- | (5%) 3.36M to 3.2M | |
| 05-Oct-17 8:19 PM View: | Witte Owen N. Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 5,715 | -- | -- | (9%) 64.25K to 58.53K | |
| 05-Oct-17 8:20 PM View: | Champsi Farah Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 1,807 | -- | -- | (3%) 63.27K to 61.47K | |
| 05-Oct-17 8:25 PM View: | Kazam Joshoa A Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 70,050 | $180.00 | $12,609,000.00 | (94%) 74.41K to 4.36K | |
| 05-Oct-17 8:26 PM View: | Nussbaum Ran Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 9,832 | -- | -- | (100%) 9.83K to 0 | |
| 05-Oct-17 8:15 PM View: | Wiezorek Jeffrey SVP Clinical Development | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 11,150 | -- | -- | (43%) 25.82K to 14.67K | |
| 05-Oct-17 8:12 PM View: | Chang David D EVP, R&D, Chief Medical Off. | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 16,605 | $180.00 | $2,988,900.00 | (100%) 16.61K to 0 | |
| 05-Oct-17 8:16 PM View: | Tomasello Shawn Chief Commercial Officer | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 16,135 | $180.00 | $2,904,300.00 | (100%) 16.14K to 0 | |
| 05-Oct-17 8:24 PM View: | Humer Franz B Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 4,624 | $180.00 | $832,320.00 | (100%) 4.62K to 0 | |
| 05-Oct-17 8:22 PM View: | Bonderman David Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 4,360 | -- | -- | (< 1%) 2.41M to 2.41M | |
| 05-Oct-17 8:10 PM View: | Belldegrun Arie Chairman, President and CEO Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 3,197,270 | $180.00 | $575,507,968.00 | (100%) 3.2M to 0 | |
| 05-Oct-17 8:25 PM View: | Kazam Joshoa A Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 1,807 | -- | -- | (41%) 4.36K to 2.55K | |
| 05-Oct-17 8:25 PM View: | Kazam Joshoa A Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 2,553 | $180.00 | $459,540.00 | (100%) 2.55K to 0 | |
| 05-Oct-17 8:17 PM View: | Moore Timothy L. EVP, Technical Operations | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 3,927 | $180.00 | $706,860.00 | (100%) 3.93K to 0 | |
| 05-Oct-17 8:13 PM View: | Jenkinson Paul L Chief Financial Officer | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 9,462 | -- | -- | (76%) 12.46K to 3.0K | |
| 05-Oct-17 8:20 PM View: | Champsi Farah Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 61,467 | $180.00 | $11,064,100.00 | (100%) 61.47K to 0 | |
| 05-Oct-17 8:15 PM View: | Wiezorek Jeffrey SVP Clinical Development | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 14,674 | $180.00 | $2,641,320.00 | (100%) 14.67K to 0 | |
| 05-Oct-17 8:14 PM View: | Kim Helen Susan EVP, Business Development | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 4,193 | $180.00 | $754,740.00 | (100%) 4.19K to 0 | |
| 05-Oct-17 8:27 PM View: | Clark Ian T Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 5,324 | -- | -- | (75%) 7.1K to 1.78K | |
| 05-Oct-17 8:23 PM View: | Doumani Roy Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 150,620 | $180.00 | $27,111,600.00 | (86%) 175.69K to 25.07K | |
| 05-Oct-17 8:14 PM View: | Kim Helen Susan EVP, Business Development | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 17,500 | -- | -- | (81%) 21.69K to 4.19K | |
| 05-Oct-17 8:17 PM View: | Moore Timothy L. EVP, Technical Operations | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 41,734 | -- | -- | (91%) 45.66K to 3.93K | |
| 05-Oct-17 8:22 PM View: | Bonderman David Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 2,408,080 | -- | -- | (100%) 2.41M to 0 | |
| 05-Oct-17 8:19 PM View: | Witte Owen N. Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 58,535 | $180.00 | $10,536,300.00 | (100%) 58.53K to 0 | |
| 05-Oct-17 8:26 PM View: | Nussbaum Ran Director | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 4,360 | -- | -- | (31%) 14.19K to 9.83K | |
| 05-Oct-17 8:13 PM View: | Jenkinson Paul L Chief Financial Officer | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 3,000 | $180.00 | $540,000.00 | (100%) 3.0K to 0 | |
| 05-Oct-17 8:20 PM View: | Champsi Farah Director | Kite Pharma, Inc. (KITE) | 29-Sep-17 | Gift | 2,800 | -- | -- | (4%) 66.07K to 63.27K | |
| 05-Oct-17 8:25 PM View: | Kazam Joshoa A Director | Kite Pharma, Inc. (KITE) | 28-Sep-17 | Acquisition (other) | 70,050 | -- | -- | 1607% 4.36K to 74.41K | |
| 27-Sep-17 9:44 PM View: | Tomasello Shawn Chief Commercial Officer | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Market Sale | 4,203 | $179.66 | $755,127.00 | (6%) 65.27K to 61.07K | (< 1%) |
| 27-Sep-17 9:42 PM View: | Moore Timothy L. EVP, Technical Operations | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Market Sale | 4,228 | $179.66 | $759,619.00 | (8%) 49.89K to 45.66K | (< 1%) |
| 27-Sep-17 9:39 PM View: | Jenkinson Paul L Chief Financial Officer | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Grant | 2,500 | -- | -- | 23% 10.91K to 13.41K | |
| 27-Sep-17 9:41 PM View: | Wiezorek Jeffrey SVP Clinical Development | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Market Sale | 5,283 | $179.66 | $949,164.00 | (17%) 31.11K to 25.82K | (< 1%) |
| 27-Sep-17 9:43 PM View: | Kim Helen Susan EVP, Business Development | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Market Sale | 3,171 | $179.66 | $569,714.00 | (13%) 24.86K to 21.69K | (< 1%) |
| 05-Oct-17 8:16 PM View: | Tomasello Shawn Chief Commercial Officer | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Gift | 5,000 | -- | -- | (8%) 61.07K to 56.07K | |
| 27-Sep-17 9:43 PM View: | Kim Helen Susan EVP, Business Development | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Grant | 6,000 | -- | -- | 32% 18.86K to 24.86K | |
| 27-Sep-17 9:38 PM View: | Belldegrun Arie Chairman, President and CEO Director | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Grant | 50,000 | -- | -- | 2% 3.28M to 3.33M | |
| 27-Sep-17 9:42 PM View: | Moore Timothy L. EVP, Technical Operations | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Grant | 8,000 | -- | -- | 19% 41.89K to 49.89K | |
| 27-Sep-17 9:40 PM View: | Chang David D EVP, R&D, Chief Medical Off. | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Grant | 15,000 | -- | -- | 30% 50.35K to 65.35K | |
| 27-Sep-17 9:38 PM View: | Butitta Cynthia M Chief Operating Officer | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Grant | 8,000 | -- | -- | 7% 117.8K to 125.8K | |
| 27-Sep-17 9:44 PM View: | Tomasello Shawn Chief Commercial Officer | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Grant | 4,500 | -- | -- | 7% 60.77K to 65.27K |
